BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 18, 2006
View Archived Issues
IND filing for XL-281
Read More
R-1626 begins phase II trials in chronic hepatitis C
Read More
Agreement for humanization of BioArctic's antibody for Alzheimer's disease
Read More
Phoqus to advance Chronocort into phase II trials for adrenal insufficiency
Read More
Delay to gaboxadol NDA filing
Read More
G-4460 studied in phase I trial in advanced cancer
Read More
End-of-phase II meeting for NRP-290
Read More
Taiho follows committee's advice on gastric cancer study of TS-1
Read More
Improved outcomes with Surfaxin in bronchopulmonary dysplasia
Read More
Polidocasklerol for varicose veins set for December launch in Japan
Read More
Novo Nordisk withdraws E.U. application to expand repaglinide product labels
Read More
Neurochem submits complete response to Kiacta approvable letter
Read More
BVT-28949 begins phase II study for glaucoma
Read More
Tezampanel begins phase IIb for treatment of acute migraine
Read More
AD-337 studied in fibromyalgia syndrome proof-of-principle study
Read More
Ad5-TRAIL gene therapy studied in phase I for prostate cancer
Read More
XEN-D0101 begins phase I development for atrial fibrillation
Read More
New data presented at EADV on agents under development at Barrier Therapeutics
Read More
Retapamulin effective in treating impetigo
Read More
Preclinical studies detail CNS-7056X characteristics
Read More
New therapeutics for cancer covered in recent patent literature
Read More
Novel agents for thrombotic disorders reported in recent Pfizer and Fournier patents
Read More
New peptides for treating wrinkles reported by Rohto
Read More
Novel choline analogue enhances cognition in monkeys
Read More
Targeting sEH as a novel strategy for inflammatory pain relief
Read More
SP-04 and its metabolite: a novel therapeutic approach for Alzheimer's disease
Read More
Spotlight on novel macrolide derivatives developed at Enanta
Read More
FDA accepts NDA for zileuton CR
Read More
Januvia approved for type 2 diabetes
Read More
NovoSeven approved for acquired hemophilia
Read More